Business / Finance

RSS

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol) in the US, in line with the Daiichi Sankyo strategy to expand its US portfolio through strategic alliances, in addition to internal R&D and acquisitions.

19 Mar 2015

Ensocare to serve as authorized re-seller for iMPak's medication management system

An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak's innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare's Sync and Connect software engines.

19 Mar 2015

Janssen announces acquisition of XO1

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab.

19 Mar 2015

SST Group to become exclusive distributor for MPTronic's RDM solution in U.S. and Canada

SST Group, Inc., a leading provider of DICOM distribution solutions in the United States, is excited to announce its partnership with MPTronic, a leading developer of Radiation Dose Monitoring systems in Europe, Middle East and Africa.

18 Mar 2015

RMANJ acquires IVF New Jersey

Reproductive Medicine Associates of New Jersey, a world-renowned leader in the field of infertility, today announced the strategic acquisition of IVF New Jersey Fertility and Gynecology Center, one of the largest fertility centers in New Jersey.

18 Mar 2015

Columbia Laboratories' revenues increase 11% to $32.5 million in 2014

Columbia Laboratories, Inc., today announced financial results for the three- and twelve-month periods ended December 31, 2014.

18 Mar 2015

PlanSource expands U.S. presence with ClearBenefits acquisition

PlanSource, which provides the leading cloud-based health exchange and benefits engagement platform, today announced the acquisition of the ClearBenefits benefits administration business from BENU, Inc. located in San Mateo, CA.

18 Mar 2015

DigiPath, Blue Line sign preferred supplier marketing and resource-sharing agreement

DigiPath, Inc., the independent digital pathology and cannabis testing, education, and media firm, has entered into a preferred supplier marketing and resource-sharing agreement with Blue Line Protection Group.

18 Mar 2015

Gentronix signs three-year technology access deal with SIMM

UK based Gentronix Limited, the specialist genetic toxicology company, today announced it has signed a three year technology access deal with one of China's most prestigious research intensive institutes, Shanghai Institute Materia Medica, Chinese Academy of Sciences.

18 Mar 2015

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.

18 Mar 2015

BD announces completion of CareFusion acquisition

Becton, Dickinson and Company today announced that it completed its acquisition of CareFusion Corporation pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").

From BD (Becton, Dickinson and Company) 17 Mar 2015

Janssen Pharmaceutical to invest $10 million in global Dementia Discovery Fund

Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.

17 Mar 2015

Kennedy Funding Financial completes $3.5 million loan for Lifestyle Real Estate I

Kennedy Funding Financial LLC has completed a $3.5 million loan for Lifestyle Real Estate I, LP, announced Gregg Wolfer, COO of the Englewood Cliffs, NJ-based direct private lender. The borrower is an affiliate of Lifestyle Healthcare Group (LHG), and the collateral is a 10.31-acre tract of vacant land in Bensalem Twp., Bucks County, PA. LHG has received approval from the township for a $185 million medical office campus.

17 Mar 2015

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.

16 Mar 2015

Fast and focused sequencing from single genes to entire exomes

Integrated DNA Technologies (IDT) will host a talk on maximizing efficiency of NGS enrichment panels at the qPCR & NGS 2015 Advanced Molecular Diagnostics for Biomarker Discovery Symposium on Monday March 23rd at 3PM. The talk will detail current technical issues faced by researchers when using hybridization enrichment panels and provide practical advice on how to increase successes while reducing time and costs in targeted sequencing.

From Integrated DNA Technologies 16 Mar 2015

Preventing falls in care homes: an interview with Professor Pip Logan

Older people living in care homes fall three times more frequently than individuals who still live in their own homes. There is often debate over the idea of people going into care homes as a solution to the fact they are falling at home but they can still fall in the care home.

16 Mar 2015

Egalet announces net revenues of $1.9 million for 2014

Egalet Corporation today reported financial results for the year ended December 31, 2014.

16 Mar 2015

Ruthigen, Pulmatrix sign definitive merger agreement

Ruthigen, Inc., a biopharmaceutical company, and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that on March 13, 2015, they have entered into a definitive merger agreement.

16 Mar 2015

Experts call for a tobacco-free world by 2040

Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades.

16 Mar 2015

Boris backs Bump Mark with £20,000 prize

Brunel graduate Solveiga Pakstaite has added the Mayor of London’s Low Carbon Entrepreneur prize to the Dyson Award she won for her innovative final-year food label project – the Bump Mark.

16 Mar 2015